Xerophthalmia

3

Review clinical trials related to Xerophthalmia. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Exosomes Proteomic for Sjogren's Syndrome and Dry Eye Syndrome

By analyzing the differential proteins in exosomes, this study aims to understand the pathological mechanisms of SJS and DES, identify potential diagnostic and therapeutic methods, and advance the diagnosis and treatment of these diseases.

Participants needed: 220
Trial details
Age: 20-75Biological sex: AllType: ObservationalSponsor: Taipei Veterans General Hospital, TaiwanUpdated: Jan 17, 2025Locations: 1
Eligibility criteria

Not listed

Status: Recruiting

Clinical Study for the Evaluation of Safety and Tolerability of NCP112 Eye Drops

The objective is to evaluate the safety, local tolerability, and pharmacokinetics of NCP112 eye drops through single and multiple dose-escalation ocular administrations in healthy adults.

Participants needed: 60
Trial details
Phase: Phase 1Age: 19-50Biological sex: AllType: InterventionalSponsor: Huons Co., Ltd.Updated: Oct 1, 2024Locations: 1
Eligibility criteria

Healthy adult subjects aged 19 to 50 years at the time of screening (Visit 1). [+3]

Subjects with clinically significant diseases or history of diseases related to... [+29]

Status: Not yet recruiting

Exosome-miRNA and Transcriptome Profiling of Dry Eye Syndrome and Sjogren's Syndrome

This study combines data from two trials testing acupuncture (ACUDES) and a Chinese herbal tea bag TBDESJS for Dry Eye Syndrome and Sjögren's syndrome. Both treatments improved tear production. Researchers will now analyze participants' blood remaining samples and other data to understand how these therapies work. They will use advanced methods to identify tiny RNA molecules and immune system activity. This integrated approach aims to explain how acupuncture and TBDESJS improve dryness and support their use in managing these conditions.

Participants needed: 220
Trial details
Age: 20-75Biological sex: AllType: ObservationalSponsor: Taipei Veterans General Hospital, TaiwanUpdated: Jun 26, 2024Locations: 1
Eligibility criteria

aged between 20 and 75 years Schirmer's test less than 10 mm/5 min

Inclusion Criteria: primary or secondary SS aged between 20 and 75 years fulfill... [+3]